PROX1 and colorectal carcinoma: Survival analyses showed shorter disease-free survival (DFS) in patients with late-stage CRC (Figure 5E) and considerably shorter DFS in patients with PROX1+ CRC than in those with PROX1- CRC (Figure 5F).